I wouldn't rely on my short term predictions. Apparently short term we should have all been shorting this thing...... But it certainly looks like it's about to get oversold significantly ...... then likely move back up some. The whole "cash value" thing really just is going to get crushed. No data from this new trial or outcome as far as the NDA until late NEXT year...... they're going to use up all their cash just trying to get this drug to the market. I'm baffled as to what to do short term at this moment myself. Just say F* it and hold....? I had a LOT of money invested in this. It's disappointing. Obviously, the long term implications here are still the same. But after holding for almost a year, to find out its going to take over another year before any sort of outcome as far as getting the drug approved, sucks a big one.
Good luck go all
News 
Market Data 
Discover 
